Business Description
Scandinavian ChemoTech AB
ISIN : SE0009242654
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.22 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.01 | |||||
Beneish M-Score | -2.66 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 93.4 | |||||
3-Year EBITDA Growth Rate | 13.6 | |||||
3-Year EPS without NRI Growth Rate | 15.1 | |||||
3-Year FCF Growth Rate | 14.8 | |||||
3-Year Book Growth Rate | -26.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 86.86 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.38 | |||||
9-Day RSI | 40.14 | |||||
14-Day RSI | 43.45 | |||||
6-1 Month Momentum % | -10.67 | |||||
12-1 Month Momentum % | -12.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.41 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 773.2 | |||||
Days Sales Outstanding | 240.7 | |||||
Days Payable | 493.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -43.5 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.61 | |||||
Operating Margin % | -344.46 | |||||
Net Margin % | -368.11 | |||||
FCF Margin % | -291.57 | |||||
ROE % | -210.55 | |||||
ROA % | -101.23 | |||||
ROIC % | -97.28 | |||||
ROC (Joel Greenblatt) % | -20238.79 | |||||
ROCE % | -190.21 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.43 | |||||
PB Ratio | 10.53 | |||||
EV-to-EBIT | -2.97 | |||||
EV-to-EBITDA | -3.47 | |||||
EV-to-Revenue | 9.87 | |||||
EV-to-FCF | -3.39 | |||||
Earnings Yield (Greenblatt) % | -33.67 | |||||
FCF Yield % | -28.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Scandinavian ChemoTech AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 4.613 | ||
EPS (TTM) (kr) | -0.997 | ||
Beta | 0 | ||
Volatility % | 41.11 | ||
14-Day RSI | 43.45 | ||
14-Day ATR (kr) | 0.253187 | ||
20-Day SMA (kr) | 2.169 | ||
12-1 Month Momentum % | -12.91 | ||
52-Week Range (kr) | 1.571021 - 4.996521 | ||
Shares Outstanding (Mil) | 23.34 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Scandinavian ChemoTech AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Scandinavian ChemoTech AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Scandinavian ChemoTech AB Frequently Asked Questions
What is Scandinavian ChemoTech AB(OSTO:CMOTEC B)'s stock price today?
When is next earnings date of Scandinavian ChemoTech AB(OSTO:CMOTEC B)?
Does Scandinavian ChemoTech AB(OSTO:CMOTEC B) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |